Use of glucocorticoids and azithromycin in the therapy of COVID-19

In December 2019, a new variant coronavirus, SARS-CoV-2, emerged in China, which was initially described as a pneumonia of an unknown agent. The new coronavirus spreads mainly by person-to-person transmission through close contact. The pathophysiology of COVID-19 is related to a complex immune syste...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lemos Neto, Miguel, Alexandre, Rafael Costa Vieira, Morra, Rafaela Oliveira Gallart, da Paz, Juliana Aparecida Souza, Barroso, Shana Priscila Coutinho, Resende, Angela Castro, de Medeiros-Lima, Daniel J. M., Alexandre, Pedro Celso Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175191/
https://www.ncbi.nlm.nih.gov/pubmed/34085181
http://dx.doi.org/10.1007/s43440-021-00286-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175191/
https://www.ncbi.nlm.nih.gov/pubmed/34085181
http://dx.doi.org/10.1007/s43440-021-00286-4

Ejemplares similares